Envomed 80 on-site medical and infectious waste treatment system selected by HUS Helsinki University Hospital
Maabarot Metal Works Ltd (MMW) is delighted to announce that the HUS Helsinki University Hospital in Finland has chosen its flagship machine, the Envomed 80, to treat their medical and infectious waste on-site – saving at least 30% in waste treatment costs for the hospital.
About the Envomed 80
The Envomed 80 is a scientifically driven, onsite solution for Medical Waste treatment. Totally unique in the market today, the Envomed 80 shreds and sterilizes medical waste simultaneously, using a scientifically developed and proven technology which has the ability to sterilize medical waste to STAATT level IV. Offering the HUS Helsinki University Hospital an extremely powerful & environmentally friendly solution, the Envomed 80 can treat 80 litres of infectious and sharps medical waste in just 15 minutes.
Environmentally friendly, the Envomed 80 has a lower carbon footprint than alternative treatment solutions on the market today. It was developed by Maabarot Metal Works Ltd, a company with extensive technical knowledge and over 30 years’ experience in providing specialized industrial machinery.
Identifying the market’s need for efficient on-site medical waste treatment facilities, MMW made significant investments in R&D and engineered a solution that is revolutionary from economic, safety and environmental perspectives.
A non-compromise game changing solution, The Envomed 80 unit offers fully comprehensive validation using both the solid and liquid phases of real infectious waste, including the presence of protein, hemoglobin, carbohydrate, lipids and insoluble fibers.
Its sterilization process consistently demonstrates a 6 LOG10/ml bacterial spores’ reduction, which complies with STAATT level IV, according to the ISTAATT guidelines (both in the liquid and solid phases). Currently, the Envomed 80 is the only on-site medical waste treatment technology approved by the Israeli Ministry of Health due to the above comprehensive validation requirements.
About HUS Helsinki University Hospital
HUS is the biggest health care provider and the second largest employer in Finland. More than half a million patients receive medical care at the HUS Helsinki University Hospital every year.
With 25,000 professionals working for the best of all patients, HUS is responsible for providing specialized health care for the residents of its 24 member municipalities. In addition, the treatment of many rare and severe diseases is nationally centralized to HUS.
Historical Waste Treatment at the HUS
HUS Diagnostic Centre produced a total of 156,127 kg of data protected biological waste in 2018, of which 82.732 kg (53%) came from HUS Diagnostic Centre house units, as well as bacteriology and pathology at Haartmaninkatu 3. HUS Diagnostic Centre’s other locations in the Meilahti area (sampling and blood centre) produced 1.877 kg (1.2%) of the corresponding waste.
HUS Diagnostic Centre’s data protected biological waste has to date been processed by a contractor as bio-hazardous biological waste. The cost of this bio-waste retrieved is significant, accounting for about 30% of the total waste cost.
As a university hospital, HUS continuously develops and evaluates their treatment methods and activities. Therefore, a decision was taken to seek both ecological and financial savings by sourcing an on-site medical waste treatment solution.
After a rigorous selection process, the Envomed 80 was confirmed as the HUS Helsinki University Hospital’s solution of choice for on-site medical waste treatment.
The Envomed 80 will be installed at the HUS Helsinki University Hospital during Q4, 2020 and it is anticipated that the decision to move their medical waste treatment on-site, using the Envomed 80 make the hospital significant savings in off-site treatment costs every year.
David Segev, Envomed CEO commented: “It is fantastic that a hospital as forward-thinking as the HUS has recognised the potential of the Envomed 80 to truly revolutionise their medical waste treatment processes and make significant savings in the process”.
“Most countries still use giant off-site, high energy consuming waste treatment solutions with dramatically high carbon footprints which are costly from financial, environmental and public health perspectives. In addition, many traditional existing on-site solutions, based on heat treatment, struggle to treat medical waste – particularly liquids – effectively”.
“The Envomed 80 however, is already starting to change all that. Bringing to market a scientifically-driven, on-site solution capable of treating up to 80 liters of sharps and infectious medical waste in just 15 minutes, the Envomed 80 is revolutionizing the world of medical waste treatment”.
Mr. Erkki Matikainen from Diagnostica medical Oy – Envomed’s distributor in Finland commented: “We are delighted the HUS has selected Envomed as its Medical Waste Treatment supplier of choice. The innovative technology behind the Envomed 80 has made it easier for hospitals to lay aside any conservative mindset and make positive changes to their medical waste treatment practices and we look forward to helping the HUS realise the rewards of their investment from both economic and environmental perspectives”.
For press enquires and interview requests please contact : firstname.lastname@example.org. Tel: +44 7927 840 176
Interviews available with: Mr. David Segev, Envomed CEO / Mr. Erkki Matikainen, Diagnostica medical Oy.
With global headquarters in Israel and a network of distributors all over the world, Envomed has a truly global outlook. Building on Israel’s reputation for driving engineering excellence, Envomed is backed by over 30 years of experience and engineering know-how gained by parent company Maabarot Metal Works Ltd. In
fact, the technology behind the Envomed 80 has already been approved by the Israeli Ministry of Health. Following its debut at the world’s largest medical trade-fair, MEDICA, in 2019, Envomed will continue to be present at all major medical tradeshows around the world. The Envomed 80 is already beginning to revolutionise the world of on-site medical waste treatment with pilots in APAC, South America and in Israel which is Envomed’s local market.